AngioDynamics, Inc. (ANGO) earnings
ANGO earnings moved a median of +0.18% by the close. Quarterly and annual ANGO reports and results, each read against the price at its own news timestamp. Back to the ANGO overview →
17 measured ANGO earnings events.
Where these ANGO earnings landedvs 17 measured ANGO earnings reactions
| Middle 50% of ANGO earnings reactions | -1.10% to +1.03% |
|---|---|
| Median reaction (to close) | +0.18% |
| Measured reactions | 17 |
Point-in-time · zero look-ahead
Half of the 17 ANGO earnings events with a measured close landed between -1.10% and +1.03%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ANGIODYNAMICS INC For: Aug 31 | SEC filing · Form 10-Q | +0.00% | -1.84% | |
| Form 10-K/A ANGIODYNAMICS INC For: May 31 | SEC filing · Form 10-K | -0.32% | +0.39% | |
| AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026 | Press release | -0.32% | +0.39% | |
| Form 10-K ANGIODYNAMICS INC For: May 31 | SEC filing · Form 10-K | -0.91% | -1.06% | |
| Form 10-Q ANGIODYNAMICS INC For: Feb 28 | SEC filing · Form 10-Q | +0.14% | -1.62% | |
| AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026 | Press release | -0.05% | +0.66% | |
| Form 10-Q ANGIODYNAMICS INC For: Nov 30 | SEC filing · Form 10-Q | -0.10% | -0.27% | |
| AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026 | Press release | -0.11% | -2.81% | |
| Form 10-Q ANGIODYNAMICS INC For: Aug 31 | SEC filing · Form 10-Q | +1.91% | -1.10% | |
| AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025 | Press release | -0.23% | +0.18% | |
| Form 10-K ANGIODYNAMICS INC For: May 31 | SEC filing · Form 10-K | +0.47% | +2.54% | |
| Form 10-Q ANGIODYNAMICS INC For: Feb 28 | SEC filing · Form 10-Q | +1.02% | +1.21% | |
| Form 10-Q ANGIODYNAMICS INC For: Nov 30 | SEC filing · Form 10-Q | +1.07% | +6.24% | |
| Form 10-Q ANGIODYNAMICS INC For: Aug 31 | SEC filing · Form 10-Q | -4.05% | -4.98% | |
| Form 10-K ANGIODYNAMICS INC For: May 31 | SEC filing · Form 10-K | +1.47% | +1.86% | |
| Form 10-Q ANGIODYNAMICS INC For: Feb 29 | SEC filing · Form 10-Q | +2.36% | +1.03% | |
| Form 10-Q ANGIODYNAMICS INC For: Nov 30 | SEC filing · Form 10-Q | +2.87% | -0.16% |
Keep exploring
More ANGO: analyst actions → · SEC filings → · ANGO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Lipocine Inc. (LPCN) | 219 | +0.34% | 52% |
| Mettler-Toledo International, Inc. (MTD) | 219 | -0.10% | 39% |
| Anixa Biosciences, Inc. (ANIX) | 217 | 0.00% | 49% |
| Entera Bio Ltd. - Ordinary Shares (ENTX) | 217 | 0.00% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.